LiquiVida Wellness Therapy Franchise For Sale
Liquivida® is the leader in the IV vitamin therapy industry and is fully diversified in its products and services. It serves customer needs ranging from anti-aging, medical aesthetics, and weight loss, along with personal beauty and care.
The US healthcare industry is broken. But we’re partnering with the best in modern medicine to make a difference in our communities and around the world. By focusing on the larger population, we believe we can proactively keep people healthy, so they can live more active and fulfilling lifestyles.
Why LiquVida?
· Proprietary Custom I.V. Drip Technology
· Multiple Revenue Streams: Products & Services
· Comprehensive Training & Ongoing Support
· Program Affiliated with Over 4000 Doctors
· No Medical License Required
· Membership model
· Multiple revenue streams
$ 398,000
Fitness & Wellness Businesses for Sale
Bars, Pubs & Nightclubs for Sale
Warehouse & Storage Businesses for Sale
Construction & Landscaping Businesses for Sale
Beauty & Personal Care Businesses for Sale
Smoke & Vape Shops for Sale
Finance & Accounting Businesses for Sale
Coffee Shop, Bakery & Dessert Businesses for Sale
Printing, Signs & Publishing Businesses for Sale
Retail Businesses for Sale
Catering Franchise Opportunities
Automotive Franchises for Sale
Smoke & Vape Shop Franchises for Sale
Consultancy & Training Franchise Opportunities
Restaurant Franchises for Sale
Vending & Kiosk Franchises for Sale
Healthcare & Medical Franchise Opportunities
Warehouse & Storage Franchise for Sale
Convenience Store & Lotto Franchises for Sale
Coffee, Bakery & Dessert Franchise Opportunities
Office Spaces for Sale or Rent
Houses & Condos for Sale or Lease
Mixed Use Buildings for Sale or Rent
Industrial Units for Sale or Rent
Medical Buildings for Sale or Lease
Apartment Buildings for Sale
Office Buildings for Sale or Rent
Plazas for Sale
Retail Buildings for Sale or Lease
Commercial Spaces for Sale or Lease
An email will be sent to registered email address.
Please select if you are: